Advanced search
1 file | 524.71 KB

Regulatory development of geriatric medicines : to GIP or not to GIP?

(2016) AGEING RESEARCH REVIEWS. 27. p.23-36
Author
Organization
Keywords
Geriatric, Regulatory affairs, Drug formulation, Drug development, Aging, Clinical trials, BLOOD-BRAIN-BARRIER, ADVERSE DRUG-REACTIONS, QUALITY-OF-LIFE, OLDER-PEOPLE, CLINICAL-TRIALS, ALZHEIMERS-DISEASE, AGE, DELIVERY, ADULTS, PHARMACOKINETICS

Downloads

    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 524.71 KB

Citation

Please use this url to cite or link to this publication:

Chicago
De Spiegeleer, Bart, Evelien Wynendaele, Nathalie Bracke, Lieselotte Veryser, Lien Taevernier, Agnes Degroote, and Sofie Stalmans. 2016. “Regulatory Development of Geriatric Medicines : to GIP or Not to GIP?” Ageing Research Reviews 27: 23–36.
APA
De Spiegeleer, B., Wynendaele, E., Bracke, N., Veryser, L., Taevernier, L., Degroote, A., & Stalmans, S. (2016). Regulatory development of geriatric medicines : to GIP or not to GIP? AGEING RESEARCH REVIEWS, 27, 23–36.
Vancouver
1.
De Spiegeleer B, Wynendaele E, Bracke N, Veryser L, Taevernier L, Degroote A, et al. Regulatory development of geriatric medicines : to GIP or not to GIP? AGEING RESEARCH REVIEWS. 2016;27:23–36.
MLA
De Spiegeleer, Bart, Evelien Wynendaele, Nathalie Bracke, et al. “Regulatory Development of Geriatric Medicines : to GIP or Not to GIP?” AGEING RESEARCH REVIEWS 27 (2016): 23–36. Print.
@article{7097546,
  author       = {De Spiegeleer, Bart and Wynendaele, Evelien and Bracke, Nathalie and Veryser, Lieselotte and Taevernier, Lien and Degroote, Agnes and Stalmans, Sofie},
  issn         = {1568-1637},
  journal      = {AGEING RESEARCH REVIEWS},
  keyword      = {Geriatric,Regulatory affairs,Drug formulation,Drug development,Aging,Clinical trials,BLOOD-BRAIN-BARRIER,ADVERSE DRUG-REACTIONS,QUALITY-OF-LIFE,OLDER-PEOPLE,CLINICAL-TRIALS,ALZHEIMERS-DISEASE,AGE,DELIVERY,ADULTS,PHARMACOKINETICS},
  language     = {eng},
  pages        = {23--36},
  title        = {Regulatory development of geriatric medicines : to GIP or not to GIP?},
  url          = {http://dx.doi.org/10.1016/j.arr.2016.02.004},
  volume       = {27},
  year         = {2016},
}

Altmetric
View in Altmetric
Web of Science
Times cited: